Skip to main content

CMS takes next step in Medicare drug price negotiations with pharma companies

By Reuters  
   April 03, 2024

The Biden administration said on Tuesday it has responded to offers from the manufacturers of 10 high-cost drugs selected for the U.S. Medicare program's first-ever pricing negotiations, but provided no details.

Full story

Get the latest on healthcare leadership in your inbox.